Agile therapeutics granted 180-day extension by nasdaq to meet the minimum bid price requirement

Princeton, n.j., feb. 27, 2023 (globe newswire) -- agile therapeutics, inc. (nasdaq: agrx) (“agile” or the “company”), a women's healthcare company, today announced that it has received written notification from the listing qualifications department of the nasdaq stock market llc (“nasdaq”) granting the company's request for a 180-day extension to regain compliance under nasdaq listing rule 5550(a)(2). the company now has until august 14, 2023 to meet the requirement (the “compliance date”).
AGRX Ratings Summary
AGRX Quant Ranking